Hon Dr MEGAN WOODS: There are five central pillars to this strategy, which acknowledge the complexity and interconnectedness of the vaccine challenge. The pillars are: connecting New Zealand researchers globally to contribute to all aspects of vaccine development, distribution, and use; investing in research that contributes to global efforts, builds relationships, and supports early access to a vaccine; developing the ability to manufacture in case it is needed to secure supply; optimising regulatory approaches to ensure safety, to support research, and to enable domestic manufacturing; and using our purchasing arrangements, managed by Pharmac, to secure supply where possible and to enhance resilience. The vaccine strategy will also feed into and support immunisation strategy and planning as safe and effective vaccines are developed.